Anaconda BioMed

About

Anaconda Biomed S.L. is a medical device startup based in Barcelona, founded in 2015 by Dr. Marc Ribó and Dr. Ofir Arad. The company specializes in developing advanced thrombectomy systems aimed at treating ischemic stroke. Its flagship product, the ANA Funnel Catheter, is designed to enhance navigability and safety during mechanical thrombectomies, showing promising clinical results. The company is committed to improving stroke care through innovative research and collaboration, with a focus on high safety standards. Anaconda Biomed has raised over €35 million in funding to support its mission, which includes a €25 million Series C round for clinical validations and global commercialization. The company holds 15 patent families, ensuring protection for its unique technologies in key markets. With a dedicated team and strategic partnerships, Anaconda Biomed aims to minimize stroke-related deaths and disabilities, ultimately enhancing the quality of life for patients and their families.